Publications by authors named "P Joly"

Claim this Profile
S
Skin-adverse drug reactions in the elderly: An underestimated and avoidable issue.
M Lagassy, A Lefebvre, P Carvalho, P Joly, F Roca

Ann Dermatol Venereol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune bullous dermatosis in children: French guidelines.
A Welfringer-Morin, B Tedbirt, H Aubert, E Abi-Nader, B Pigneur, P Joly

Ann Dermatol Venereol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of persistent hypogammaglobulinaemia in children with autoimmune bullous dermatoses treated with rituximab.
S Benkimoun, A Welfringer-Morin, V Barlogis, R Gravier Dumonceau, E Bourrat, P Joly

J Eur Acad Dermatol Venereol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a novel SERPINA1 variant carrying two missense mutations: molecular mechanisms and functional impact.
Celine Leon, Marie-Françoise Odou, Bertrand Roquelaure, Louis Lebreton, Mathias Ruiz, Philippe Joly

Orphanet J Rare Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bullous Pemphigoid Outcome Measurement: A Scoping Review of Outcome Heterogeneity and Trends in Clinical Research of Treatments.
Marjolein A J Hiel, Billal Tedbirt, Eva W H Korte, Maria C Bolling, Joost M Meijer, Pascal Joly

Br J Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis